Target intelligence / Profile preview

DNA cross-linking agent binding site on DNA strands

Molecular classification
Other, Nucleic acid modification target
01

Overview

The "DNA cross-linking agent binding site on DNA strands" refers not to a single molecule but rather the specific loci within double-stranded genomic DNA where certain chemotherapeutic agents covalently bind. These sites are typically nitrogen atoms or oxygen atoms within nucleobases—most commonly guanine's N7 position—and occasionally adenine or cytosine residues. The covalent attachment forms either interstrand or intrastrand bridges between bases that physically prevent the normal unwinding and separation of the two complementary strands required for essential cellular processes such as replication and transcription. This blockade leads ultimately to replication fork stalling, activation of cell cycle checkpoints, apoptosis induction if damage persists unrepaired. Crosslink formation can also involve proteins bound near these sites resulting in bulky lesions called DNA-protein crosslinks which further complicate genome maintenance. Agents that induce these lesions include nitrogen mustards, platinum-based drugs like cisplatin, mitomycin C, psoralens among others—all widely used anticancer drugs exploiting this mechanism selectively against rapidly proliferating tumor cells. The efficacy depends heavily upon cellular capacity for lesion recognition and removal through complex repair pathways involving nucleotide excision repair enzymes and homologous recombination factors. In summary, this "target" represents critical chemical interaction points exploited pharmacologically rather than classical biological macromolecules like receptors or enzymes[1][2][3][4].

Other names
DNA interstrand crosslink siteDNA intrastrand crosslink siteDNA-protein crosslink binding regionalkylation sites on DNA strands
02

Mechanism of action

Drugs bind covalently to nucleotides at defined positions such as guanine N7, adenine N1/N3/N7, cytosine N3, thymidine O4 forming: - Interstrand crosslinks that link complementary strands preventing strand separation. - Intrastrand crosslinks within one strand causing helix distortion. - Crosslinks between proteins and DNA blocking enzymatic processes. This prevents unwinding necessary for replication/transcription leading to cell death if unrepaired.

03

Biological functions

Blocking of DNA strand separation during replication and transcriptionInduction of replication arrestTriggering cell cycle arrest and apoptosis when unrepairedMediating cytotoxic effects of chemotherapeutic agentsInvolvement in genomic stability maintenance via repair pathways
04

Disease associations

Cancer (targeted by chemotherapeutics to kill rapidly dividing tumor cells)Genomic instability-related diseases due to defective repair mechanisms
05

Safety considerations

Significant toxicity due to off-target effects including:Myelosuppression from bone marrow toxicityNephrotoxicity and neurotoxicity with platinum compounds like cisplatinSecondary malignancies from mutagenesis caused by alkylation damageTherapeutic challenges include development of resistance via enhanced repair or drug efflux.
06

Interacting drugs

Nitrogen mustard analogs (alkylating agents)

4 more in the full profile.

07

Biomarkers

No direct biomarkers for the binding sites themselves; however, biomarkers related to drug response include:Expression levels/mutations in nucleotide excision repair genes (e.g., ERCC1)Homologous recombination repair status (e.g., BRCA1/2 mutations)

Beyond the preview

Go deeper on DNA cross-linking agent binding site on DNA strands.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA cross-linking agent binding site on DNA strands.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call